HomeCompareNYMX vs PEP

NYMX vs PEP: Dividend Comparison 2026

NYMX yields 1000.50% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NYMX wins by $18926778.66M in total portfolio value
10 years
NYMX
NYMX
● Live price
1000.50%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18926778.81M
Annual income
$15,816,909,097,826.86
Full NYMX calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — NYMX vs PEP

📍 NYMX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNYMXPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NYMX + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NYMX pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NYMX
Annual income on $10K today (after 15% tax)
$85,042.52/yr
After 10yr DRIP, annual income (after tax)
$13,444,372,733,152.83/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, NYMX beats the other by $13,444,372,680,558.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NYMX + PEP for your $10,000?

NYMX: 50%PEP: 50%
100% PEP50/50100% NYMX
Portfolio after 10yr
$9463389.47M
Annual income
$7,908,454,579,851.27/yr
Blended yield
83.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

NYMX
No analyst data
Altman Z
-1079.3
Piotroski
3/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NYMX buys
0
PEP buys
0
No recent congressional trades found for NYMX or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNYMXPEP
Forward yield1000.50%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$18926778.81M$141.9K
Annual income after 10y$15,816,909,097,826.86$61,875.67
Total dividends collected$18689176.71M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NYMX vs PEP ($10,000, DRIP)

YearNYMX PortfolioNYMX Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$110,750$100,050.03$10,849$509.42+$99.9KNYMX
2$1,154,067$1,035,564.75$11,969$750.47+$1.14MNYMX
3$11,319,965$10,085,113.06$13,500$1,124.14+$11.31MNYMX
4$104,563,222$92,450,859.72$15,680$1,721.66+$104.55MNYMX
5$909,989,518$798,106,870.01$18,929$2,715.34+$909.97MNYMX
6$7,465,033,954$6,491,345,169.85$24,023$4,450.80+$7465.01MNYMX
7$57,755,143,367$49,767,557,036.19$32,510$7,669.92+$57755.11MNYMX
8$421,647,934,611$359,849,931,208.39$47,709$14,093.60+$421647.89MNYMX
9$2,906,420,287,179$2,455,256,997,145.24$77,415$28,083.48+$2906420.21MNYMX
10$18,926,778,805,108$15,816,909,097,826.86$141,922$61,875.67+$18926778.66MNYMX

NYMX vs PEP: Complete Analysis 2026

NYMXStock

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.

Full NYMX Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this NYMX vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NYMX vs SCHDNYMX vs JEPINYMX vs ONYMX vs KONYMX vs MAINNYMX vs MONYMX vs PMNYMX vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.